Hereditary Angiodema (HAE)
Attune Pharmaceuticals is advancing therapies for Hereditary Angiodema (HAE), a rare and potentially life-threatening genetic condition characterized by recurring episodes of severe swelling.
Attune Pharmaceuticals is advancing therapies for Hereditary Angiodema (HAE), a rare and potentially life-threatening genetic condition characterized by recurring episodes of severe swelling.